#697 — The Industry Wire

  1. FDA shifts away from animal testing for drug development
  2. Prospect’s beleaguered Penn. hospitals get last-minute lifeline
  3. Medicare Advantage contracts squeeze rural hospitals.
  4. ‘Chaos and questions’ at U.S. health agencies
  5. NIH reverses conference attendance ban for scientists
  6. Healthcare welcomes pause to tariff turmoil
  7. Novartis to spend $23B on U.S. drug plants.
  8. Medicare paid Medicare Advantage $38B for non-Medicare services.
  9. Employers are willing to pay for anti-obesity meds.
  10. One-third of maternal deaths happen long after delivery
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Imaging Wire team

You're all set!